Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT06018857 |
Recruitment Status :
Active, not recruiting
First Posted : August 31, 2023
Last Update Posted : January 30, 2024
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Hepatocellular Carcinoma |
Study Type : | Observational |
Estimated Enrollment : | 1000 participants |
Observational Model: | Cohort |
Time Perspective: | Retrospective |
Official Title: | Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation |
Actual Study Start Date : | May 11, 2017 |
Estimated Primary Completion Date : | December 2024 |
Estimated Study Completion Date : | December 2024 |
- Recurrence Free Survival [ Time Frame: From date of surgery to date of identified cancer recurrence through either clinical judgement or scans. This is assessed up to 10 years after the surgery. ]
- Overall Survival [ Time Frame: From date of surgery to date of death, up to 10 years after the surgery. ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Adult patients (age>18 years) undergoing Liver transplant for hepatocellular carcinoma
Exclusion Criteria:
- Patients under 18 years old
- Patients who do not have hepatocellular carcinoma
- patients who have hepatocellular carcinoma but do not undergo liver transplantation
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06018857
United States, Ohio | |
Cleveland Clinic Foundation | |
Cleveland, Ohio, United States, 44195 | |
Ohio State University | |
Columbus, Ohio, United States, 43210 |
Principal Investigator: | Federico Aucejo, MD | The Cleveland Clinic |
Responsible Party: | Federico Aucejo, Director Liver Cancer Program, The Cleveland Clinic |
ClinicalTrials.gov Identifier: | NCT06018857 |
Other Study ID Numbers: |
17-009 |
First Posted: | August 31, 2023 Key Record Dates |
Last Update Posted: | January 30, 2024 |
Last Verified: | January 2024 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Carcinoma, Hepatocellular Adenocarcinoma Carcinoma Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms |
Liver Neoplasms Digestive System Neoplasms Neoplasms by Site Digestive System Diseases Liver Diseases |